Immunogenicity of modified vaccinia virus Ankara expressing the hemagglutinin stalk domain of pandemic (H1N1) 2009 influenza virus
Sign Up to like & getrecommendations! Published in 2017 at "Pathogens and Global Health"
DOI: 10.1080/20477724.2016.1275464
Abstract: Abstract Background: Vaccination offers protection against influenza, although current vaccines need to be reformulated each year. The development of a broadly protective influenza vaccine would guarantee the induction of heterosubtypic immunity also against emerging influenza… read more here.
Keywords: modified vaccinia; influenza; vaccinia virus; virus ankara ... See more keywords
Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers
Sign Up to like & getrecommendations! Published in 2017 at "AIDS Research and Human Retroviruses"
DOI: 10.1089/aid.2016.0251
Abstract: Abstract We explored the duration of immune responses and the effect of a late third HIV-modified vaccinia virus Ankara (MVA) boost in HIV-DNA primed and HIV-MVA boosted Tanzanian volunteers. Twenty volunteers who had previously received… read more here.
Keywords: modified vaccinia; hiv; vaccinia virus; virus ankara ... See more keywords
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
Sign Up to like & getrecommendations! Published in 2022 at "Vaccines"
DOI: 10.3390/vaccines10091516
Abstract: Modified vaccinia virus Ankara (MVA) is a promising viral vector for vaccine development. MVA is well studied and has been widely used for vaccination against smallpox in Germany. This review describes the history of the… read more here.
Keywords: virus ankara; development; modified vaccinia; vaccinia virus ... See more keywords